Applied Biosystems, a division of Life Technologies
(NASDAQ:LIFE), and its mass spectrometry joint-venture partner, MDS
Analytical Technologies, a business unit of MDS Inc. (TSX:MDS)
(NYSE:MDZ), today announced that the AB SCIEX QTRAP� 5500 System, a
unique, next-generation mass spectrometer, has received the
Scientists� Choice Award for Best New Spectroscopy Product by
SelectScience.net, a leading online resource for applied chemists,
clinical chemists and life scientists. This award was based on the
results of an independent poll of more than 25,000 scientists, who
were asked to nominate and vote for their favorite new spectroscopy
products.
The AB SCIEX QTRAP 5500 System is the only system on the market
that combines qualitative and quantitative analysis capabilities in
a single system. This uniquely enables scientists to identify and
confirm a greater number of compounds, proteins and contaminants in
a single analysis, rather than having to utilize two different
technologies to achieve the same results. This system was developed
as a powerful tool for the increasing number of scientists who are
adopting mass spectrometry for a wide variety of laboratory
applications, such as drug discovery, food testing, environmental
analysis and the study of diseases.
�SelectScience is honored to present Applied Biosystems/MDS
Analytical Technologies with the Scientists� Choice Award for Best
New Spectroscopy Product of 2008,� said Kerry Parker, Editor of
SelectScience.net. �This new system clearly has captured the
imagination of the scientific community as evidenced by its
tremendous popularity in such a brief period on the market. The
Scientists� Choice Award provides a unique channel for the online
community to voice opinions, and provide feedback to manufacturers,
about which new products have significantly contributed towards
laboratory research efforts.�
The AB SCIEX 5500 System, which was launched in October of last
year, is the newest addition to the comprehensive portfolio of
industry-leading LC/MS/MS mass spectrometry systems, software and
workflow applications from Applied Biosystems/MDS Analytical
Technologies. For qualitative analysis, this system features a new
innovation in ion trap technology known as Linear Accelerator�
Trap, which is combined with industry-leading triple quadrupole
capabilities used for quantitative analysis to create an
innovative, one-of-a-kind system.
�Scientists are seeking best-in-class mass spectrometry
solutions to help drive new discoveries and improve health and
safety,� said Laura Lauman, President of Life Technologies� Mass
Spectrometry Systems Division. �The Scientists� Choice Award for
the AB SCIEX QTRAP 5500 System confirms that we have once again set
a new standard for mass spectrometry instruments and that the
scientific community is quickly embracing this unique
technology.�
Andy Boorn, President of MDS Analytical Technologies, which
developed the award-winning instrument, added: �The AB SCIEX QTRAP
5500 System is one of the most advanced mass spectrometry systems
ever built. We designed it based upon feedback from the scientific
community regarding what they needed a next-generation mass
spectrometry platform to achieve; therefore, this award validates
our approach to developing breakthrough technologies that are truly
differentiated from other available systems.�
Applied Biosystems is a global leader in providing innovative
instrument systems to accelerate academic and clinical research,
drug discovery and development, pathogen detection and forensic DNA
analysis. It is a leading provider of mass spectrometry solutions
through its joint venture with MDS Analytical Technologies. Applied
Biosystems, along with Invitrogen � a leading provider of platform
independent, essential life science technologies for disease and
drug research, bioproduction and diagnostics � is part of Life
Technologies. Applied Biosystems and Invitrogen products are used
in nearly every major laboratory in the world.
For more information, please visit: www.appliedbiosystems.com
and www.invitrogen.com.
About Life Technologies
Life Technologies Corporation (NASDAQ:LIFE) is a global
biotechnology tools company dedicated to improving the human
condition. Our systems, consumables and services enable researchers
to accelerate scientific exploration, driving to discoveries and
developments that make life even better. Life Technologies
customers do their work across the biological spectrum, working to
advance personalized medicine, regenerative science, molecular
diagnostics, agricultural and environmental research, and 21st
century forensics. Life Technologies had sales of more than $3
billion in 2008, employs approximately 9,500 people, has a presence
in more than 100 countries, and possesses a rapidly growing
intellectual property estate of approximately 3,600 patents and
exclusive licenses. Life Technologies was created by the
combination of Invitrogen Corporation and Applied Biosystems Inc.
For more information on how we are making a difference please visit
our website: www.lifetechnologies.com.
About MDS Analytical Technologies
MDS Analytical Technologies, a business unit of MDS Inc.
(TSX:MDS) (NYSE:MDZ), is focused on the research, design,
manufacture and marketing of state-of-the-art tools for
mass-spectrometry, drug discovery and bioresearch. MDS Analytical
Technologies� products are designed to help accelerate the complex
process of discovering and developing new drug compounds, and are
sold to research scientists around the world. The mass-spectrometer
product lines are also sold globally through joint ventures with
two of the world�s leading analytical instrumentation and
life-sciences companies, Life Technologies Corporation and
PerkinElmer, Inc. Find out more at www.mdssciex.com or
www.moleculardevices.com.
Safe Harbor Statement
This press release includes forward-looking statements about our
anticipated results that involve risks and uncertainties. Some of
the information contained in this press release, including, but not
limited to, statements as to industry trends and Life Technologies�
plans, objectives, expectations and strategy for its business,
contains forward-looking statements that are subject to risks and
uncertainties that could cause actual results or events to differ
materially from those expressed or implied by such forward-looking
statements. Any statements that are not statements of historical
fact are forward-looking statements. When used, the words
�believe,� �plan,� �intend,� �anticipate,� �target,� �estimate,�
�expect� and the like, and/or future tense or conditional
constructions (�will,� �may,� �could,� �should,� etc.), or similar
expressions, identify certain of these forward-looking statements.
Important factors which could cause actual results to differ
materially from those in the forward-looking statements are
detailed in filings made by�Life Technologies with the Securities
and Exchange Commission.�Life Technologies undertakes no obligation
to update or revise any such forward-looking statements to reflect
subsequent events or circumstances.
Copyright 2009. Life Technologies Corporation. All rights
reserved. Linear Accelerator is a trademark and QTRAP is a
registered trademark of Applied Biosystems/MDS Analytical
Technologies, a joint venture between Life Technologies and MDS
Inc.
Photos/Multimedia�Gallery Available:
http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5920001&lang=en
Mds (NYSE:MDZ)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Mds (NYSE:MDZ)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
